The Department of Health and Human Services (HHS) has issued a Draft Request for Proposals (RFP) for the purchase of 25 million doses of a recombinant protective antigen (rPA) anthrax vaccine that would be delivered in the Strategic National Stockpile. Acceptance of the rPA anthrax vaccine into the stockpile will be contingent upon the contractor providing sufficient safety, immunogenicity, efficacy, stability, manufacturing and any other data and information as determined by the Food and Drug Administration for potential use of…
HHS Releases Draft RFP for rPA Anthrax Vaccine
SHARE: